South African HP resellers that work with Tarsus Distribution can access a full catalogue of the latest tech solutions, ...

Lyme disease is on the rise. But scientists are searching for ways to prevent it.

Alongside Alkeus, several companies like Belite Bio, Ocugen and Nanoscope are aiming to secure a place on the Stargardt market where there are no approved therapies.

Abraham Koomson has called for stronger monitoring and accountability in the implementation of government policies after the ...

St. Paul Global Week brings pilgrims to Tarsus, Türkiye, from 28 to 30 June 2027 for a three-day gathering in the Apostle ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

IRVINE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (“Tarsus”) today announced that it has entered into a securities purchase agreement with certain qualified ...

Adds a potential blockbuster opportunity with gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt disease, one of the ...

OSN calendar page, and you will find more than three dozen meetings, symposia and summits that make up a year of ...

Eye drugmaker Tarsus Pharmaceuticals said on Thursday ​it would acquire privately held Alkeus Pharmaceuticals in a ‌cash-and-stock deal worth up to $800 million, adding an experimental oral therapy ...

Bobak Azamian (Co-Founder, President, CEO & Chairman) said, "Today is an important day for Tarsus. We're reporting another exceptional quarter for XDEMVY and announcing the acquisition of Alkeus ...